Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
Dr. Berenbrok serves as the Director of the University of Pittsburgh School of Pharmacy's long-standing SilverScripts program, a project to help seniors better manage their medications, which reaches upwards of 400 Pittsburgh seniors every year. He also serves as the Chair of the University Senate Benefits and Welfare Committee and as the Director of the University of Pittsburgh's Comprehensive Medication Management Benefit for faculty and staff. With faculty members from the School of Pharmacy and School of Medicine, Dr. Berenbrok leads the implementation of clinical pharmacogenomics services in outpatient settings.
At the School of Pharmacy, Dr. Berenbrok mentors students with interests in changing community pharmacy practice through enhanced community pharmacy services and innovative research. He coordinates first and second year courses focused on patient-provider communication, clinical skills, and motivational interviewing using standardized patients. He also coordinates experiential learning and skills-based courses focused in community and ambulatory care practice. He currently leads the implementation of an educational electronic health record and entrustable professional activities within the PharmD curriculum.
Dr. Berenbrok received his PharmD in 2013 from the University of Pittsburgh School of Pharmacy. Afterwards, he completed a one-year community pharmacy practice residency with Kerr Drug and Walgreens at the University of North Carolina Eshelman School of Pharmacy which focused on enhanced community pharmacy patient care services. He received his Master of Science in Clinical Research at the University of Pittsburgh School of Medicine in 2017 and is Board Certified in Ambulatory Care Pharmacy by the Board of Pharmacy Specialties. Dr. Berenbrok serves as a faculty advisor to the University of Pittsburgh chapters of the American Pharmacists Association-Academy of Student Pharmacists, Kappa Psi Pharmaceutical Fraternity, Inc., and Interprofessional Student Board.
FDA approves first daily over-the-counter birth control pill, Opill
Jul 17, 2023 13:02 pm UTC| Business Health
On July 13, 2023, the U.S. Food and Drug Administration approved a drugmakers application for the first daily over-the-counter birth control pill for people seeking to prevent pregnancy. The pill, called Opill the...
Oct 31, 2022 08:43 am UTC| Health
The U.S. Food and Drug Administration is set to review a drugmakers application for the first over-the-counter birth control pill in November 2022, with a decision expected in the first half of 2023. An approved...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight